Financing Pharmaceutical Expenditures in OECD Countries: Modern State and Tendencies

Tatiana V. Chubarova ()
Additional contact information
Tatiana V. Chubarova: Institute of Economics Russian Academy of Sciences

Finansovyj žhurnal — Financial Journal, 2014, issue 3, 47-58

Abstract: This article discusses the problems оf financing of medicines supply in OECD countries. Detailed analysis of the statistical data is provided in the three basic positions, viz the total pharmaceutical expenditures, the level of consumption of medicines and the extent of the use of generics. This allows to compare the situation in health care systems in these countries in terms of developing policy, aimed at securing population assess to medicine. The author concludes that is necessary to continue the analysis of the characteristics and the institutional structure of the pharmaceutical market and its regulation by the state for the optimization of the health care cost.

Keywords: pharmaceutical policies; health expenditures; pharmaceutical expenditures; medicines consumption; generics use (search for similar items in EconPapers)
Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.nifi.ru/images/FILES/Journal/Archive/2014/3/05_3_2014.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fru:finjrn:140305:p:47-58

Access Statistics for this article

Finansovyj žhurnal — Financial Journal is currently edited by Vladimir S. Nazarov

More articles in Finansovyj žhurnal — Financial Journal from Financial Research Institute, Moscow 125375, Russia Contact information at EDIRC.
Bibliographic data for series maintained by Gennady Ageev ().